Switching to A 6-Monthly Triptorelin Formulation for Prostate Cancer (Pca) Reduces Patient-Nhs Interactions and Hospital Resource use: Real World Evidence (Rwe) from Project Deserve (Decapeptyl Service Evaluation).

Subjects

Subjects :

*PROSTATE cancer treatment
*HOSPITAL costs
*MEDICAL informatics
*DRUG formularies
*MEDICAL care costs

Details

Language :

English

ISSN :

10983015

Volume :

18

Issue :

7

Database :

Academic Search Index

Journal :

Value in Health

Publication Type :

Academic Journal

Accession number :

110430363

Full Text :

https://doi.org/10.1016/j.jval.2015.09.1319